SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-024547
Filing Date
2022-10-24
Accepted
2022-10-24 06:08:45
Documents
19
Period of Report
2022-10-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20221021_8k.htm   iXBRL 8-K 36047
2 EXHIBIT 4.1 ex_435243.htm EX-4.1 35436
3 EXHIBIT 10.1 ex_435416.htm EX-10.1 33003
4 EXHIBIT 99.1 ex_435394.htm EX-99.1 13763
9 a01.jpg GRAPHIC 14885
10 a02.jpg GRAPHIC 12434
11 logo01.jpg GRAPHIC 9028
  Complete submission text file 0001437749-22-024547.txt   318251

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA stab-20221018.xsd EX-101.SCH 3603
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20221018_def.xml EX-101.DEF 11921
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20221018_lab.xml EX-101.LAB 15968
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20221018_pre.xml EX-101.PRE 12132
13 EXTRACTED XBRL INSTANCE DOCUMENT cbli20221021_8k_htm.xml XML 2672
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 221324773
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences